Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis
Clinical trial NCT00745069 · COMPLETED
Trial details
- NCT number
- NCT00745069
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.